These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12789606)

  • 1. Recent progress toward the clinical development of new anti-MRSA antibiotics.
    Long TE
    IDrugs; 2003 Apr; 6(4):351-9. PubMed ID: 12789606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-MRSA beta-lactams in development.
    Page MG
    Curr Opin Pharmacol; 2006 Oct; 6(5):480-5. PubMed ID: 16899405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
    Mishra RK; Revell KD; Coates CM; Turos E; Dickey S; Lim DV
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2081-3. PubMed ID: 16464583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of the development of antibiotic resistance in Staphylococcus aureus.
    Schito GC
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():3-8. PubMed ID: 16445718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
    Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of antibiotics combined with natural polyphenols against clinical methicillin-resistant Staphylococcus aureus (MRSA).
    Lin RD; Chin YP; Hou WC; Lee MH
    Planta Med; 2008 Jun; 74(8):840-6. PubMed ID: 18546080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome.
    Fuda CC; Fisher JF; Mobashery S
    Cell Mol Life Sci; 2005 Nov; 62(22):2617-33. PubMed ID: 16143832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
    Cunha BA
    Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
    Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
    J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New agents in development for the treatment of bacterial infections.
    Abbanat D; Morrow B; Bush K
    Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
    Samra Z; Ofer O; Shmuely H
    Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
    Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management.
    Lewis JS; Ellis MW
    Curr Opin Infect Dis; 2007 Dec; 20(6):568-73. PubMed ID: 17975405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica.
    Brown PD; Ngeno C
    Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.